Mexico Computed Tomography Market Size (2024 - 2029)

The computed tomography market in Mexico is poised for significant growth, driven by an increasing prevalence of chronic diseases such as cancer and diabetes, alongside advancements in technology and research and development activities. Despite the setbacks caused by the COVID-19 pandemic, which temporarily disrupted healthcare services and delayed imaging procedures, the market is recovering and expected to expand over the forecast period. The demand for computed tomography is further bolstered by its critical role in diagnosing various conditions, including neurological disorders. However, challenges such as high equipment costs, limited reimbursement options, and stringent regulatory requirements may hinder the market's expansion.

Market Size of Mexico Computed Tomography Industry

Market Snapshot
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 159.35 Million
Market Size (2029) USD 215.78 Million
CAGR (2024 - 2029) 6.25 %
Market Concentration Medium

Major Players

Mexico Computed Tomography Market Major Players

*Disclaimer: Major Players sorted in no particular order

Mexico Computed Tomography Market Analysis

The Mexico Computed Tomography Market size is estimated at USD 159.35 million in 2024, and is expected to reach USD 215.78 million by 2029, growing at a CAGR of 6.25% during the forecast period (2024-2029).

The COVID-19 pandemic resulted in lockdowns in Mexico, due to which hospitals were not able to operate at full capacity. Many clinical studies were canceled, as most imaging treatments were delayed, and all the conventional imaging studies CT scans were canceled. According to the circumstances in various regions of the country in March 2020, several appointments were rescheduled or canceled since imaging treatments were seen as elective treatments. The quantity of computed tomography scans reduced as a result of movement restrictions and social distance norms. Global Citizen Organization records show that the COVID-19 pandemic delayed Mexico's already meager testing in March 2021. In 2020 compared to 2019, there were fewer diagnoses because of the pandemic's strain on the healthcare system, which decreased by more than half. Data from the Organization for Economic Co-operation and Development (OECD) show that there were 2.1 fewer medical consultations per person in 2020 than there were in 2019, a decline from 2.3 in 2019. The market for computed tomography in Mexico was significantly damaged by the aforementioned issues. The market is reverting to pre-pandemic levels as COVID-19 instances decline, but it will take a long time to finish all the computed tomography procedures that were put off. Thus, the market will keep growing in the long term.

The increasing frequency of chronic diseases including cancer, diabetes, neurological disorders, etc. is what drives the computed tomography market in Mexico. The market for the nation is additionally fueled by the expanding technological developments in the relevant markets, expanding R&D activities, increasing investments, and expanding product launches. Mexico had 195,449 new cases of cancer in 2020, and GLOBOCAN 2020 projects that this figure will rise to 323,432 cases of cancer by 2040. The country's CT scanner market will be driven by the anticipated increase in cancer cases because CT scanners are used to diagnose different types of cancer. Thus, during the projection period, the market under study is anticipated to have significant growth. Mexico is one of the 29 countries in the IDF North America and Caribbean area where adults are more likely to have diabetes than non-diabetics (15.2%), with 12,805,200 cases overall in the nation. Diabetes will likely cause more cancer cases in the nation, which is expected to raise demand for the product being studied. Another factor boosting the growth of the computed tomography market for neurology applications is the rising prevalence of epilepsy in Mexico. The prevalence of epilepsy was higher in developing nations, including Mexico, in 2020, according to Anales Médicos de la Asociación Médica del Centro Médico ABC. According to the same report, Mexico has epilepsy prevalence rates ranging from 3.9 to 42.2 per 1,000 people. The usage of computed tomography for diagnostic brain imaging will rise along with the prevalence of epilepsy cases in Mexico. Consequently, the market under study will grow. Similar to this, a study conducted in August 2021 at the Centro de Investigación in Computación, Instituto Politécnico Nacional, Mexico, by Solorio-Ramrez et al. found that CT images are the most frequently used for the diagnosis of cerebral haemorrhages due to their high quality. The section is projected to grow as a result of such studies on the application of computed tomography for neurological illnesses. Thus, the abovementioned factors are expected to increase the market growth.

The high cost of equipment and CT scan procedures, the absence of adequate reimbursement, the strict regulatory clearance processes, and these factors are anticipated to restrain market expansion in Mexico.

Mexico Computed Tomography Industry Segmentation

As per the scope of the report, computed tomography (CT), also known as computerized axial tomography (CAT) scanning, is an imaging process that customizes special X-ray equipment to generate a sequence of exhaustive images or scans of areas inside the body. It is primarily used in cancer diagnosis. Mexico Computed Tomography Market is segmented by Type (Low Slice, Medium Slice, and High Slice), Application (Oncology, Neurology, Cardiovascular, Musculoskeletal, and Other Applications), and End User (Hospitals, Diagnostic Centers, and Other End Users). The report offers the value (in USD million) for all the above segments.

By Type
Low Slice
Medium Slice
High Slice
By Application
Oncology
Neurology
Cardiovascular
Musculoskeletal
Other Applications
By End User
Hospitals
Diagnostic Centers
Other End Users
Need A Different Region Or Segment?
Customize Now

Mexico Computed Tomography Market Size Summary

The Mexico computed tomography market is poised for significant growth over the forecast period, driven by the increasing prevalence of chronic diseases such as cancer, diabetes, and neurological disorders. The market is recovering from the setbacks caused by the COVID-19 pandemic, which had led to a decline in imaging procedures due to lockdowns and the reclassification of many imaging treatments as elective. As the healthcare system stabilizes and the backlog of postponed procedures is addressed, the demand for computed tomography is expected to rise. Technological advancements, increased research and development activities, and strategic investments are further propelling the market forward. The anticipated rise in cancer cases, coupled with the growing need for diagnostic imaging in neurology, particularly for conditions like epilepsy, is expected to drive the adoption of CT scanners in Mexico.

Despite the promising growth prospects, the market faces challenges such as high equipment costs, inadequate reimbursement frameworks, and stringent regulatory processes. However, the advantages of computed tomography over traditional imaging methods and the strategic initiatives by key players to enhance cancer diagnosis are expected to mitigate these challenges. The market is moderately competitive, with major players like Carestream Health, GE Healthcare, and Koninklijke Philips NV leading the charge. Initiatives such as the deployment of Nanox.ARC devices in Mexico aim to improve healthcare standards and are likely to contribute to market expansion. Overall, the combination of increasing disease prevalence, technological advancements, and strategic market initiatives is set to drive the growth of the computed tomography market in Mexico.

Explore More

Mexico Computed Tomography Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Chronic Diseases

      2. 1.2.2 Rising Geriatric Population

      3. 1.2.3 Increasing Technological Advancements

    3. 1.3 Market Restraints

      1. 1.3.1 Lack Of Proper Reimbursement And Stringent Regulatory Approval Procedures

      2. 1.3.2 High Cost of Equipment

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Type

      1. 2.1.1 Low Slice

      2. 2.1.2 Medium Slice

      3. 2.1.3 High Slice

    2. 2.2 By Application

      1. 2.2.1 Oncology

      2. 2.2.2 Neurology

      3. 2.2.3 Cardiovascular

      4. 2.2.4 Musculoskeletal

      5. 2.2.5 Other Applications

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Diagnostic Centers

      3. 2.3.3 Other End Users

Mexico Computed Tomography Market Size FAQs

The Mexico Computed Tomography Market size is expected to reach USD 159.35 million in 2024 and grow at a CAGR of 6.25% to reach USD 215.78 million by 2029.

In 2024, the Mexico Computed Tomography Market size is expected to reach USD 159.35 million.

Mexico Computed Tomography Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)